De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

MedAdvisor Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Rick Ratliff

Algemeen directeur

AU$1.5m

Totale compensatie

Percentage CEO-salaris	46.9%
Dienstverband CEO	2.3yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2yrs
Gemiddelde ambtstermijn bestuur	3.2yrs

Recente managementupdates

Recent updates

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Nov 09

Is MedAdvisor (ASX:MDR) A Risky Investment?

Oct 11

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Mar 08

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

Feb 10

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

Jan 18

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

Dec 22

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

Dec 18

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

Nov 22

Analyse CEO-vergoeding

Hoe is Rick Ratliff's beloning veranderd ten opzichte van MedAdvisor's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$2m	AU$723k	AU$792k
Mar 31 2024	n/a	n/a	-AU$4m
Dec 31 2023	n/a	n/a	-AU$9m
Sep 30 2023	n/a	n/a	-AU$10m
Jun 30 2023	AU$2m	AU$678k	-AU$11m

Compensatie versus markt: De totale vergoeding ($USD 1.06M ) Rick } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 680.95K ).

Compensatie versus inkomsten: De vergoeding van Rick is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Rick Ratliff

2.3yrs

Tenure

AU$1,542,426

Compensatie

Mr. Richard Ratliff, also known as Rick, MBA IT, BChE serves as Chief Executive Officer & Managing Director and Director at MedAdvisor Limited since July 15, 2022. He serves as Chief Commercial Officer at...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Ratliff	CEO, MD & Director	2.3yrs	AU$1.54m	geen gegevens
Ancila Desai	CFO & Joint Company Secretary	2yrs	AU$837.50k	geen gegevens
Craig Schnuriger	Acting Chief Technology Officer	4.6yrs	geen gegevens	geen gegevens
James Rotsart	Executive VP of US & Client Relations	no data	geen gegevens	geen gegevens
Wayne Marinoff	President of ANZ	1.8yrs	geen gegevens	geen gegevens
Anshu Raghuvanshi	Joint Company Secretary	1.6yrs	geen gegevens	geen gegevens

2.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van MDR wordt beschouwd als ervaren (gemiddelde ambtstermijn 2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Ratliff	CEO, MD & Director	2.3yrs	AU$1.54m	geen gegevens
Linda Jenkinson	Independent Non-Executive Chairman	2.7yrs	AU$531.73k	geen gegevens
Kevin Hutchinson	Independent Non-Executive Director	1.9yrs	AU$187.69k	0.071% A$ 151.7k
Lucas Merrow	Independent Non-Executive Director	3.2yrs	AU$137.93k	0.17% A$ 362.0k
Sandra Hook	Independent Non-Executive Director	8.8yrs	AU$202.69k	0.056% A$ 119.2k
Arthur Charlaftis	Member of Advisory Board	8.6yrs	geen gegevens	geen gegevens
Jim Xenos	Non-Executive Director	8.9yrs	AU$88.46k	1.25% A$ 2.7m
Mike Da Gama	Member of Advisory Board	8.6yrs	AU$25.89k	geen gegevens
Nick England	Member of Advisory Board	8.6yrs	geen gegevens	geen gegevens
Catherine Hill	Independent Non-Executive Director	1.4yrs	AU$131.68k	geen gegevens
Anthony Tassone	Non-Executive Director	2.3yrs	geen gegevens	geen gegevens

3.2yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MDR wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.2 jaar).

MedAdvisor Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

MedAdvisor Limited Announces the Resignation of Anthony Tassone as Non-Executive Director

MedAdvisor Limited, Annual General Meeting, Nov 14, 2024

MedAdvisor Limited Announces Board Resignations

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

MedAdvisor Limited Announces Board Changes

Recent updates

MedAdvisor Limited Announces the Resignation of Anthony Tassone as Non-Executive Director

MedAdvisor Limited, Annual General Meeting, Nov 14, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

MedAdvisor Limited Announces Board Resignations

Forecast breakeven date pushed back to 2025

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Price target increased by 13% to AU$0.51

Consensus EPS estimates upgraded to AU$0.0033 loss

Forecast breakeven date moved forward to 2025

Consensus EPS estimates fall by 11%, revenue upgraded

Why Investors Shouldn't Be Surprised By MedAdvisor Limited's (ASX:MDR) Low P/S

Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?

Forecast breakeven date pushed back to 2026

New minor risk - Profitability

Now 24% overvalued after recent price rise

Consensus estimates of losses per share improve by 33%

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

Consensus estimates of losses per share improve by 32%

Full year 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 50%

MedAdvisor Limited Announces Board Changes

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Consensus EPS estimates fall by 80%, revenue upgraded

First half 2023 earnings released: EPS: AU$0.009 (vs AU$0.02 loss in 1H 2022)

Price target increased to AU$0.40

MedAdvisor Limited Provides Revenue Guidance for the First Half of the Fiscal Year 2023

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited to Report Q1, 2023 Results on Oct 28, 2022

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited, Annual General Meeting, Nov 30, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

MedAdvisor Limited (ASX:MDR) entered a binding agreement to acquire GuildLink Pty Ltd from Guild Group Holdings Limited for AUD 8 million.

MedAdvisor Limited Announces Executive Changes

MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt

MedAdvisor Limited Announces Change of Managing Director

Price target decreased to AU$0.40

No longer forecast to breakeven

Less than half of directors are independent

MedAdvisor Limited Announces Retirement of Robert Read as CEO

Consensus forecasts updated

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited to Report First Half, 2022 Results on Feb 25, 2022

MedAdvisor Limited Appoints Raeann Grossman to the Board as A Non-Executive Director

Independent Non-Executive Director Peter Bennetto has left the company

Non-Executive Director recently sold AU$2.5m worth of stock

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Is MedAdvisor (ASX:MDR) A Risky Investment?

Less than half of directors are independent

Full year 2021 earnings released

Non-Executive Director has left the company

MedAdvisor Limited announced that it has received AUD 5.25 million in funding

New 90-day low: AU$0.34

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

First half 2021 earnings released: AU$0.029 loss per share (vs AU$0.024 loss in 1H 2020)

MedAdvisor Limited to Report First Half, 2021 Results on Feb 25, 2021

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

New 90-day low: AU$0.34

Non-Executive Chairman of the Board recently bought AU$70k worth of stock

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

MedAdvisor Limited Signs an Additional One-Year Deal with A Major Global Pharmaceutical Company

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

New 90-day low: AU$0.36

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

New 90-day low: AU$0.39

MedAdvisor Limited Extends Health Programs in the US